Reduced concentrations of soluble adhesion molecules after antioxidant supplementation in postmenopausal women with high cardiovascular risk profiles - A randomized double-blind study

Cardiology

Volumn 94, Issue 4, 2000, Pages 227-232

  Goudev, Assen ^a   Kyurkchiev, S ^b   Gergova, V ^a   Karshelova, E ^a   Georgiev, D ^c   Atar, D ^d   Kehayov, I ^b   Nachev, Ch ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

^c University Hospital of Obstetrics and Gynecology 'Maichin Dom' Bulgaria   (Bulgaria)

^d Rigshospitalet   (Denmark)

Author keywords

Adhesion molecules; Antioxidants; Cardiovascular risk; Postmenopausal women

Indexed keywords

ANTIOXIDANT; CELL ADHESION MOLECULE; CHOLESTEROL; ESTROGEN; HIGH DENSITY LIPOPROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; PLACEBO; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTERY WALL; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CELL ADHESION MOLECULES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS; WOMEN'S HEALTH;

EID: 0034449329     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047322     Document Type: Article

References (41)

1. Prevention Conference V: Beyond secondary prevention: Identifying the high risk patient for primary prevention
2. Atherosclerosis - An inflammatory disease
3. Atherosclerosis basic mechanisms. Oxidation, inflammation and genetics
4. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of the arterial inflammatory response: A new perspective
5. Endothelial nuclear factor κβ and initiation of the atherosclerotic lesion
6. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells
7. Adhesion of monocytes to vascular cell adhesion molecule-1-transduced human endothelial cells: Implication for atherogenesis
8. Levels of soluble cell adhesion molecules in patients with dyslipidemia
9. Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men
10. Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease cases
11. Aging, menopause, and free radicals
12. In vitro inhibition by estrogens of the oxidative modifications of human lipoproteins
13. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women
14. Antioxidant vitamins and coronary heart disease
15. Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease
16. Short-term hormone replacement therapy: Reduced plasma levels of soluble adhesion molecules
17. Vascular effects of estrogen and vitamin E therapies in postmenopausal women
18. Vascular effects of estrogen and cholesterol lowering therapies in hypercholesterolemic women
19. Prevention of coronary heart disease in clinical practice
20. Microalgae as food and supplement
21. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol
22. Endothelium-dependent vascular effects of pycnogenol
23. Cardioprotective and anti-oxidant effects of the terpenoid constituents ofGinkgo bilobaextract (EGb 761)
24. Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers
25. The antioxidants and cardiovascular disease. Why do we still not have the answers
26. Plasma concentration of soluble intercellular adhesion molecule 1 and risk of future myocardial infarction in apparenly healthy men
27. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
28. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis
29. Soluble vascular adhesion molecule-1 as a biohumoral correlate of atherosclerosis
30. Endothelial-dependent mechanisms of leukocyte adhesion in inflammation and atherosclerosis
31. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
32. Oxidatively modified human low-density lipoprotein stimulates leukocyte adherence to the microvascular endothelium in vivo
33. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells
34. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells
35. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells
36. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals
37. Modification of atherosclerosis by agents that do not lower cholesterol
38. Randomized control trial of vitamin E in patients with coronary heart disease: Cambridge Heart Antioxidant Study (CHAOS)
39. Vitamin E supplementation and cardiovascular risk events in high risk patients
40. The antioxidant paradox
41. Still life in oxidation hypothesis of atherogenesis